WUXI BIOLOGICS CAYMAN ADR

Watch

Share

WXXWY·98260N108·US·adr·Healthcare - Biotechnology

WXXWY (WUXI BIOLOGICS CAYMAN ADR) is held by 2 institutional investors as of Q1 2026. Largest holders: RHUMBLINE ADVISERS ($82,635), PNC FINANCIAL SERVICES GROUP, INC. ($33,800). Net institutional sentiment: Mixed.

2

Holders

Avg rating(1 Elite)

$116,435

Total Value

50% (2)

Fund Consensus

1 buying - 1 selling

Smart Money Verdict

View all

41Weak MomentumSingle Source

Institutional (13F)41

Insider (Form 4)

No data

Activist (13D/13G)

No data

Congressional (STOCK Act)

No data

Get 5 free verdicts/month - sign up in 10 seconds

See how WXXWY's score breaks down across 4 SEC sources

Holder Quality

1

★★★★★

Elite

1

★★★★

Strong

0

★★★

Solid

0

★★

Below

0

★

Weak

Held by 2 funds

1 elite

No recent insider, activist, or congressional trades found for this stock

13F: Mar 31, 2026Insider & Congress: Updated regularly

Positions (2)History

AllNewIncreasedHeldDecreasedExited

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
RHUMBLINE ADVISERS	Decreased	9,643(-6.8%)	$82,635	0.0%	-8.41%	0
PNC FINANCIAL SERVICES GROUP, INC.	Increased	3,944(+18.2%)	$33,800	0.0%	-4.46%	16

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYELI LILLY & CO

410 holders · $577.8B

UNHUNITEDHEALTH GROUP INC

409 holders · $155.8B

JNJJOHNSON & JOHNSON

391 holders · $327.3B

DHRDANAHER CORP DEL

388 holders · $82.5B

ISRGINTUITIVE SURGICAL INC

388 holders · $102.1B

TMOTHERMO FISHER SCIENTIFIC INC

387 holders · $127.1B

BSXBOSTON SCIENTIFIC CORP

386 holders · $67.5B

MRKMERCK & CO INC

381 holders · $175.6B

ABBVABBVIE INC

378 holders · $212.3B

ABTABBOTT LABORATORIES

376 holders · $108.9B

High Conviction Moves-Signal Convergence-Fund Consensus-Double-Down Signals

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer